» Articles » PMID: 31286416

Impact of International Atomic Energy Agency Support to the Development of Nuclear Cardiology in Low-and-middle-income Countries: Case of Latin America and the Caribbean

Overview
Journal J Nucl Cardiol
Date 2019 Jul 10
PMID 31286416
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular diseases (CVDs) are the leading cause of death in Latin America and the Caribbean (LAC) region as well as worldwide. Lifestyle, nutritional habits and the upsurge of obesity have contributed to the increase in the prevalence of CVDs in the region. The role of nuclear cardiology in the management of patients with CVDs is well established. Particularly, myocardial perfusion imaging is widely used in LAC countries and has been increasingly integrated into the healthcare systems in the region for the diagnosis of coronary artery disease, risk stratification and to guide patient management. In its role to support countries around the world to address their health needs through the peaceful applications of nuclear techniques, the International Atomic Energy Agency (IAEA) has provided assistance to the LAC region for the establishment and strengthening of the nuclear cardiology practice. To that extent, the IAEA provides support in building capacities of multidisciplinary teams of professionals, the provision of medical equipment and the promotion of communication and exchange of knowledge among the different stakeholders. In addition, the IAEA encourages the participation of nuclear medicine centers in international multi-center research studies. In this paper, we present some of the projects through which the IAEA has supported the LAC region, including regional technical cooperation projects and coordinated research projects related to cardiology within the current multimodality approach to cardiac imaging.

Citing Articles

Underutilisation of nuclear medicine scans at a regional hospital in Nigeria: need for implementation research.

Orunmuyi A, Lawal I, Omofuma O, Taiwo O, Sathekge M Ecancermedicalscience. 2020; 14:1093.

PMID: 33014135 PMC: 7498276. DOI: 10.3332/ecancer.2020.1093.


Partnership for the goals to reduce CVD mortality: Rowing in the same direction.

Vitola J, Fernandes-Silva M J Nucl Cardiol. 2019; 26(6):2055-2059.

PMID: 31372833 DOI: 10.1007/s12350-019-01839-0.

References
1.
Peix A, Mesquita C, Paez D, Pereira C, Felix R, Gutierrez C . Nuclear medicine in the management of patients with heart failure: guidance from an expert panel of the International Atomic Energy Agency (IAEA). Nucl Med Commun. 2014; 35(8):818-23. PMC: 4076031. DOI: 10.1097/MNM.0000000000000143. View

2.
Berrocal I, Peix A, Mut F, Shaw L, Karthikeyan G, Estrada Lobato E . Appropriate use of noninvasive ischemia testing to guide revascularization decision making following acute ST elevation myocardial infarction in Latin American countries: Results from an expert panel meeting of the International Atomic Energy Agency. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018; 37(4):237-243. DOI: 10.1016/j.remn.2018.01.005. View

3.
Peix A, Paez D . Ischemic heart disease in Latin American women current perspective and call to action. J Nucl Cardiol. 2018; 26(4):1361-1364. DOI: 10.1007/s12350-018-1459-5. View

4.
Alexanderson-Rosas E, Espinola-Zavaleta N, Garcia E, Peix A, Massardo T, Pabon L . Diastolic dyssynchrony assessment by gated myocardial perfusion-SPECT in subjects who underwent cardiac resynchronization therapy. J Nucl Cardiol. 2019; 28(4):1413-1421. DOI: 10.1007/s12350-019-01845-2. View

5.
Patel H, Doppalapudi H, Hage F . Myocardial infarction assessment by surface electrocardiography. J Nucl Cardiol. 2019; 28(4):1374-1377. DOI: 10.1007/s12350-019-01903-9. View